3 Dividend Stocks to Buy and Hold for 10 Years

Key Points Pfizer has a deep pipeline that could help improve its approved lineup and financial results over the medium term. Abbott Laboratories' core medical device business remains strong, and the company has attractive opportunities elsewhere. Medtronic's planned separation of its diabetes segment should strengthen its business. 10 stocks we like better than Pfizer › History tells us that the stock market tends to deliver competitive returns relative to other asset classes over long periods, such as a decade. And the best way to take advantage of these returns is to hold onto shares of attractive companies through thick and thin, while resisting the urge to panic-sell when the going gets rough.